Artificial Heart
This channel includes news and new technology innovations for total artificial hearts (TAH). These technologies are used in cardiovascular surgery to temporarily or permanently replace the heart in advanced heart failure patients.
News | Artificial Heart | October 26, 2016
October 26, 2016 — The U.S. Food and Drug Administration (FDA) provided an update and additional information regarding...
News | Artificial Heart | September 13, 2016
August 29, 2016 — SynCardia Systems, manufacturer of the Total Artificial Heart (TAH), announced that the judge...
News | Artificial Heart | September 09, 2016
September 9, 2016 — Carmat announced that the first implantation of its bioprosthetic artificial heart within the...
News | Cardiovascular Business | July 07, 2016
July 7, 2016 — SynCardia Systems Inc. announced that it has entered into an asset purchase agreement (APA) with an...
News | Artificial Heart | March 24, 2016
March 24, 2016 — A new documentary produced by Retro Report for The New York Times looks at the history and modern use...
News | Artificial Heart | March 18, 2016
March 18, 2016 — A surgical team at Baylor University Medical Center at Dallas successfully performed a heart...
News | Ventricular Assist Devices (VAD) | August 11, 2015
August 11, 2015 — HeartWare International Inc. announced that enrollment in the ENDURANCE2 destination therapy clinical...
News | January 30, 2015
January 30, 2015 — SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a...
SynCardia Total Artificial Heart
News | November 24, 2014
October 24, 2014 — A 19-year-old woman was successfully implanted with the SynCardia temporary Total Artificial Heart...
Feature | September 22, 2014
September 22, 2014 — Robert Littlefield, MSc, GlobalData's senior analyst covering Medical Devices, said:
“Since the...
SynCardia Systems Inc. received FDA approval to manufacture the SynCardia Total Artificial Heart with SynHall valves. The OK gives the company control over the two critical components for heart manufacturing: The valves and the unique formula for segmented polyurethane solution (SPUS), which is manufactured only by SynCardia.
Technology | August 11, 2014
August 11, 2014 — SynCardia Systems Inc. received approval in July from the U.S. Federal Drug Administration (FDA) for...
Daniel G. Tang, Virginia Commonwealth University Medical Center assistant professor of cardiothoracic surgery, explains the SynCardia Total Artificial Heart implantation procedure.
News | August 01, 2014
August 1, 2014 — For the first time, cardiac surgeons, medical professionals and the public can watch the implantation...
Technology | July 18, 2014
July 18, 2014 — The Freedom portable driver has received U.S. Food and Drug Administration (FDA) approval for use with...
ASU engineer David Frakes examines a 3-D print of an optimized, patient-specific artificial heart that was virtually implanted into a pediatric patient.
Feature | April 28, 2014
April 28, 2014 — An Arizona State University research group and medical professionals at Phoenix Children’s Hospital...
Technology | April 17, 2012
April 17, 2012 – The U.S. Food and Drug Administration (FDA) has approved a humanitarian use device (HUD) designation...
